| Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening E Quintero, A Castells, L Bujanda, J Cubiella, D Salas, Á Lanas, ... New England Journal of Medicine 366 (8), 697-706, 2012 | 1123 | 2012 |
| Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed JP Gisbert, AC Marín, AG McNicholl, M Chaparro Alimentary pharmacology & therapeutics 41 (7), 613-623, 2015 | 329 | 2015 |
| The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis JP Gisbert, AC Marín, M Chaparro The American journal of gastroenterology 111 (5), 632-647, 2016 | 206 | 2016 |
| Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice AG McNicholl, AC Marin, J Molina-Infante, M Castro, J Barrio, J Ducons, ... Gut 63 (2), 244-249, 2014 | 182 | 2014 |
| Helicobacter pylori second‐line rescue therapy with levofloxacin‐and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments JP Gisbert, M Romano, AG Gravina, P Solís‐Muñoz, F Bermejo, ... Alimentary pharmacology & therapeutics 41 (8), 768-775, 2015 | 148 | 2015 |
| Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies R Jover, P Zapater, E Polanía, L Bujanda, A Lanas, JA Hermo, J Cubiella, ... Gastrointestinal endoscopy 77 (3), 381-389. e1, 2013 | 142 | 2013 |
| A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication) AC Marin, AG McNicholl, JP Gisbert Expert opinion on pharmacotherapy 14 (7), 843-861, 2013 | 132 | 2013 |
| Human intestinal pro-inflammatory CD11c high CCR2+ CX3CR1+ macrophages, but not their tolerogenic CD11c− CCR2− CX3CR1− counterparts, are expanded in inflammatory bowel disease D Bernardo, AC Marin, S Fernández-Tomé, A Montalban-Arques, ... Mucosal immunology 11 (4), 1114-1126, 2018 | 128 | 2018 |
| Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐TNF therapy JP Gisbert, AC Marín, M Chaparro Alimentary pharmacology & therapeutics 42 (4), 391-405, 2015 | 125 | 2015 |
| Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy JP Gisbert, J Barrio, I Modolell, J Molina-Infante, AP Aisa, ... Digestive diseases and sciences 60 (2), 458-464, 2015 | 64 | 2015 |
| Helicobacter Pylori First-line And Rescue Treatments In The Presence Of Penicillin Allergy JP Gisbert, J Barrio, I Modolell, J Molina-Infante, A Perez-Aisa, ... Helicobacter 19, 130-131, 2014 | 64 | 2014 |
| Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease AC Marín, JP Gisbert, M Chaparro World Journal of Gastroenterology: WJG 21 (40), 11273, 2015 | 61 | 2015 |
| Third-line Rescue Therapy With Bismuth-containing Quadruple Regimen After Failure Of Two Treatments (with Clarithromycin And Levofloxacin) To Eradicatehelicobacter Pyloriinfection JP Gisbert, A Perez-Aisa, L Rodrigo, J Molina-Infante, I Modolell, ... Helicobacter 18, 130, 2013 | 61 | 2013 |
| Third-line Rescue Therapy With Bismuth-containing Quadruple Regimen After Failure Of Two Treatments (with Clarithromycin And Levofloxacin) To Eradicatehelicobacter Pyloriinfection JP Gisbert, A Perez-Aisa, L Rodrigo, J Molina-Infante, I Modelell, ... Helicobacter 17, 101, 2012 | 58 | 2012 |
| Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection JP Gisbert, A Perez-Aisa, L Rodrigo, J Molina-Infante, I Modolell, ... Digestive diseases and sciences 59 (2), 383-389, 2014 | 57 | 2014 |
| Sa1917 Third-Line Rescue Therapy With Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (With Clarithromycin and Levofloxacin) to Eradicate Helicobacter … JP Gisbert, AP Aisa, L Rodrigo, J Molina-Infante, I Modolell, F Bermejo, ... Gastroenterology 144 (5), S-334, 2013 | 57* | 2013 |
| Correlation between adenoma detection rate in colonoscopy-and fecal immunochemical testing-based colorectal cancer screening programs J Cubiella, A Castells, M Andreu, L Bujanda, F Carballo, R Jover, A Lanas, ... United European gastroenterology journal 5 (2), 255-260, 2017 | 55 | 2017 |
| Endoscopist characteristics that influence the quality of colonoscopy R Jover, P Zapater, L Bujanda, V Hernández, J Cubiella, M Pellisé, ... Endoscopy 48 (03), 241-247, 2016 | 55 | 2016 |
| Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential” or “concomitant” treatment to eradicate H. pylori infection JP Gisbert, J Molina-Infante, AC Marin, G Vinagre, J Barrio, AG McNicholl Scandinavian journal of gastroenterology 48 (6), 652-656, 2013 | 48 | 2013 |
| The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review L Aldars-García, AC Marin, M Chaparro, JP Gisbert International Journal of Molecular Sciences 22 (6), 3076, 2021 | 44 | 2021 |
